Approaches to use the WHO respiratory syncytial virus surveillance platform to estimate disease burden

Richard Pebody, Jocelyn Moyes, Siddhivinayak Hirve, Harry Campbell, Sandra Jackson, Ann Moen, Harish Nair, Eric A.F. Simões, Peter G. Smith, Niteen Wairagkar, Wenqing Zhang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Abstract

The World Health Organization (WHO) recently completed the first phase of a RSV surveillance pilot study in fourteen countries (two to three in each WHO region) building on the Global Influenza Surveillance and Response System (GISRS). This active surveillance strategy had several objectives including understanding RSV-related health burden in a variety of settings. A range of approaches can be used to estimate disease burden; most approaches could not be applied by participating countries in the WHO surveillance pilot. This article provides the recommendations made by WHO for strengthening and expanding the scope of the RSV surveillance in the next phase to enable burden estimation.

Original languageEnglish
Pages (from-to)615-621
Number of pages7
JournalInfluenza and other Respiratory Viruses
Volume14
Issue number6
DOIs
Publication statusPublished - 1 Nov 2020

Bibliographical note

Funding Information:
The WHO global RSV surveillance pilot project was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (Grant No. OPP1127419). The authors would like to thank all the national and international experts who participated in the informal consultations led to the development of the WHO RSV surveillance strategy. We are grateful to the RSV reference laboratories, National Influenza Centres, Public Health Laboratories and the Ministries of Health of the participating countries for piloting the RSV surveillance strategy. We acknowledge Daniel Feikin of WHO Immunization Vaccines Research for his critical review as also colleagues from the Global Influenza Program, Dept. of Infectious Hazards Management of the WHO Health Emergencies for supporting this work.

Funding Information:
The WHO global RSV surveillance pilot project was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (Grant No. OPP1127419). The authors would like to thank all the national and international experts who participated in the informal consultations led to the development of the WHO RSV surveillance strategy. We are grateful to the RSV reference laboratories, National Influenza Centres, Public Health Laboratories and the Ministries of Health of the participating countries for piloting the RSV surveillance strategy. We acknowledge Daniel Feikin of WHO Immunization Vaccines Research for his critical review as also colleagues from the Global Influenza Program, Dept. of Infectious Hazards Management of the WHO Health Emergencies for supporting this work.

Publisher Copyright:
© 2019 The World Health Organization. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.

Keywords

  • burden
  • respiratory syncytial virus
  • surveillance

Fingerprint

Dive into the research topics of 'Approaches to use the WHO respiratory syncytial virus surveillance platform to estimate disease burden'. Together they form a unique fingerprint.

Cite this